lunes, 16 de marzo de 2020

BioEdge: Coronavirus: what happened to America’s bioethics commission?

BioEdge: Coronavirus: what happened to America’s bioethics commission?

Bioedge

Coronavirus: what happened to America’s bioethics commission?
    
Let’s look at the worse-case scenario for the coronavirus epidemic in the United States. According to a report in the New York Times, experts from the US Centers for Disease Control and Prevention and universities around the world came up with some very grim figures:
  • Between 160 million and 214 million Americans could be infected
  • Between 200,000 and 1.7 million people could die
  • Between 2.4 million and 21 million Americans could require hospitalization – but the US has only about 925,000 staffed hospital beds
These catastrophic outcomes are highly unlikely. But a pandemic which might kill hundreds of thousands of people seems like a good time for President Trump to get on the phone to his bioethics commission and ask for advice.
Ooops, there isn’t one. The Administration decided not to follow the lead of Presidents Bush and Obama.
This bothers Christine Mitchell, the executive director at the Center for Bioethics at Harvard Medical School. She made a few interesting observations in an interview published in the New Yorker.
Social constraints. If a person doesn’t have health insurance and doesn’t come to be tested or treated, and if they don’t have sick-time coverage and can’t leave work, so they teach at a school, or they work at a restaurant, or do events that have large numbers of people, these are all ways in which the spread of a virus like this has to be managed—and yet can’t be managed effectively because of our social-welfare policies, not just our health-care resources…
Unprepared. I’m appalled. We didn’t get ourselves ready. We’ve had outbreaks—sars in 2003, H1N1 in 2009, Ebola in 2013, Zika in 2016. We’ve known, and the general population in some ways has known. They even have movies like “Contagion” that did a great job of sharing publicly what this is like, although it is fictional, and that we were going to have these kinds of infectious diseases in a global community that we have to be prepared to handle. And we didn’t get ourselves as ready, in most cases, as we should have. There have been all these cuts to the C.D.C. budget, and the person who was the Ebola czar no longer exists in the new Administration.
A bioethics commission. I don’t know which ethicists are advising the current Administration. The Trump Administration decided not to have a National Bioethics Commission, so there isn’t one in place. So I don’t know who’s doing that…
Allocation decisions. We are going to have to figure out how we choose who has what kinds of resources, whether it’s the testing piece, or it’s inpatient treatment, or it’s the testing of the new vaccines when we, a year or more away, get to the point where we’ve got something suitable for human testing. And then, if we’ve got vaccines to use, as we ramp those up, on whom are they used? One of the most live issues in this kind of debate is using those limited numbers of vaccines in the early days for first responders and health-care providers in order to maximize the capacity of the health-care system to treat the people for whom we don’t have enough vaccines yet. So it’s those kinds of allocation and rationing decisions that I worry about and anticipate are going to get more intense.
Michael Cook is editor of BioEdge
Bioedge

Most of today’s newsletter is devoted to the coronavirus outbreak. Send us some feedback.

Two countries at the epicentre of the outbreak are particularly interesting in their response to the crisis. Taiwan has reported 50 cases and one death. Even though it is so close to China, Korea and Japan, it has the lowest incidence per capita in the world at the moment — around 1 in every 500,000 people.

The measures Taiwan has taken have been extraordinarily effective – and apparently ignored by the international community. Why? Because Taiwan is not a member of the World Health Organization. It was forced out by the People’s Republic of China for longstanding historical and political reasons. Now the rest of the world is paying the price for WHO’s weakness.

As an op-ed in USA Today argues, Taiwan ought to be admitted to the WHO, even it if puts China’s nose out of joint. “Pandemics don’t care about human politics,” says Mia Ping-Chieh Chen.

The other country is North Korea. “The infectious disease did not flow into our country yet,” says a government newspaper. That is an astonishing achievement – no cases, no deaths. It’s better by far than Taiwan.

 
m.png
Michael Cook
Editor
BioEdge
 Comment on BioedgeFind Us on FacebookFollow us on Twitter
NEWS THIS WEEK
by Michael Cook | Mar 15, 2020
Assisted dying would benefit both those seeking assisted suicide and the public
 
 
by Michael Cook | Mar 15, 2020
Some suggest a utilitarian solution
 
 
by Michael Cook | Mar 15, 2020
An Italian doctor describes the situation in Bergamo
 
 
by Michael Cook | Mar 14, 2020
How about animal trials?
 
 
by Michael Cook | Mar 14, 2020
Where is Trump getting his advice?
 
 
by Michael Cook | Mar 14, 2020
On board they get sicker; on shore they are stigmatized
 
 
by Michael Cook | Mar 14, 2020
A dispatch from the front lines of the Reproductive Revolution in Florida    
Bioedge

BioEdge
Level 1, 488 Botany Road, Alexandria NSW 2015 Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615

No hay comentarios: